Skip to content
10-Q

Quarterly Report

Concert Pharmaceuticals, Inc.

0001367920-22-000042

← back to feed
Filed
May 5, 2022 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 2, 2022 36.33M sh
Shares Diluted Q1 2022 · Mar 31, 2022 36.69M sh
Shares Diluted Q1 2022 · Mar 31, 2021 33.89M sh
Capex Q1 2022 · Mar 31, 2022 $92K
Capex Q1 2022 · Mar 31, 2021 $92K
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$32.32M
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$20.71M
Cash And Equivalents Q1 2022 · Mar 31, 2022 $59.36M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $141.64M
Cash And Equivalents Q1 2022 · Mar 31, 2021 $89.77M
Stockholders Equity Q1 2022 · Mar 31, 2022 $76.57M
Stockholders Equity Q1 2022 · Dec 31, 2021 $112.23M
Stockholders Equity Q1 2022 · Mar 31, 2021 $114.04M
Stockholders Equity Q1 2022 · Dec 31, 2020 $131.16M
Current Liabilities Q1 2022 · Mar 31, 2022 $15.08M
Current Liabilities Q1 2022 · Dec 31, 2021 $16.12M
Total Liabilities Q1 2022 · Mar 31, 2022 $52.85M
Total Liabilities Q1 2022 · Dec 31, 2021 $53.09M
Current Assets Q1 2022 · Mar 31, 2022 $114.77M
Current Assets Q1 2022 · Dec 31, 2021 $150.33M
Total Assets Q1 2022 · Mar 31, 2022 $129.41M
Total Assets Q1 2022 · Dec 31, 2021 $165.32M
Eps Diluted Q1 2022 · Mar 31, 2022 −$1.03
Eps Diluted Q1 2022 · Mar 31, 2021 −$0.67
Eps Basic Q1 2022 · Mar 31, 2022 −$1.03
Eps Basic Q1 2022 · Mar 31, 2021 −$0.67
Sga Expense Q1 2022 · Mar 31, 2022 $5.54M
Sga Expense Q1 2022 · Mar 31, 2021 $5.49M
Rd Expense Q1 2022 · Mar 31, 2022 $30.49M
Rd Expense Q1 2022 · Mar 31, 2021 $18.5M
Net Income Q1 2022 · Mar 31, 2022 −$37.73M
Net Income Q1 2022 · Mar 31, 2021 −$22.67M
Operating Income Q1 2022 · Mar 31, 2022 −$36.03M
Operating Income Q1 2022 · Mar 31, 2021 −$23.98M
Revenue Q1 2022 · Mar 31, 2022 $0
Revenue Q1 2022 · Mar 31, 2021 $5K